# Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)

> **NCT02566252** · PHASE1 · COMPLETED · sponsor: **Pulmotect, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PUL-042 Inhalation Solution
- **DRUG:** Cromolyn Sodium
- **DRUG:** Albuterol sulfate

## Key facts

- **NCT ID:** NCT02566252
- **Lead sponsor:** Pulmotect, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02566252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02566252, "Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02566252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*